UPDATE: Oppenheimer Raises PT to $30.75 on China Kanghui Holdings Following Deal


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Oppenheimer reiterated its Outperform rating on China Kanghui Holdings (NYSE: KH) and raised its price target from $26 to $30.75Oppenheimer commented, "Medtronic announced its intent to acquire KH for $816M ($30.75/ADS), a 22.5% premium over KH's close price yesterday. The price implies 27.6x KH's FY13E EPS. KH has been one of the most rewarding investments for investors who believe in the growth potential in China healthcare industry. KH IPO'd on 8/10/2010 at $10.25, so MDT's take-out price represents 200% return vs. S&P500's 29% during the same period. We believe the deal is likely to close and raise PT from $26 to $30.75."China Kanghui Holdings closed at $25.11 on Thursday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetIntraday UpdateAnalyst RatingsOppenheimer